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Interferon g (IFN-g) priming sensitizes monocytes
and macrophages to lipopolysaccharide (LPS) stim-
ulation, resulting in augmented expression of a set
of genes including TNF. Here, we demonstrate that
IFN-g priming of LPS-stimulated TNF transcription
requires a distal TNF/LT locus element 8 kb upstream
of the TNF transcription start site (hHS-8). IFN-g stim-
ulation leads to increased DNase I accessibility of
hHS-8 and its recruitment of interferon regulatory
factor 1 (IRF1), and subsequent LPS stimulation en-
hances H3K27 acetylation and induces enhancer
RNA synthesis at hHS-8. Ablation of IRF1 or targeting
the hHS-8 IRF1 binding site in vivo with Cas9 linked
to the KRAB repressive domain abolishes IFN-g
priming, but does not affect LPS induction of the
gene. Thus, IFN-g poises a distal enhancer in the
TNF/LT locus by chromatin remodeling and IRF1
recruitment, which then drives enhanced TNF gene
expression in response to a secondary toll-like re-
ceptor (TLR) stimulus.
INTRODUCTION
Produced by natural killer cells and activated Th1 lymphocytes,
interferon g (IFN-g) sensitizes circulating monocytes and tissue-
resident macrophages, leading to augmentation of macrophage
activation after microbial recognition and toll-like receptor (TLR)
signaling (Murray, 1988). This phenomenon, known as IFN-g
priming, results in enhanced gene expression of inflammatory
cytokines such as tumor necrosis factor (TNF), interleukin 12
(IL-12), and IL-6 (Lorsbach et al., 1993; Ma et al., 1996; Pace
et al., 1983; Sanceau et al., 1991). In the case of TNF, de novo
transcription of TNF is enhanced in human monocytes primed
by IFN-g and then stimulated by lipopolysaccharide (LPS)
(Hayes and Zoon, 1993). However, the molecular mechanisms
that control IFN-g priming, and whether these mechanisms are
gene specific, are poorly understood.
The TNF gene and the genes encoding lymphotoxin-a and
lymphotoxin-b (LTA and LTB) comprise the20 kb TNF/LT locus1718 Cell Reports 9, 1718–1728, December 11, 2014 ª2014 The Autregion, which lies within the histocompatibility locus on human
chromosome 6 and mouse chromosome 17. TNF is highly and
rapidly expressed in both lymphocytes andmonocytes (Goldfeld
and Maniatis, 1989; Goldfeld et al., 1990, 1993), and its tran-
scriptional regulation occurs in a cell-type- and inducer-specific
manner. Distinct sets of transcription factors and coactivators,
including chromatin-modifying enzymes, are recruited to DNA
elements in the TNF promoter depending on the type of cell
and the type of stimulus that is received (Falvo et al., 2000a,
2000b, 2010; Tsai et al., 2000; Tsytsykova and Goldfeld, 2000).
Furthermore, the formation of higher-ordered structures, or en-
hanceosomes, is required for TNF gene expression in specific
cell types (Tsytsykova and Goldfeld, 2002; Barthel and Goldfeld,
2003). Distal hypersensitive (DH) elements upstream and down-
stream of the TNF transcription start site (TSS) have been iden-
tified in the TNF/LT locus. A subset of these DH sites also varies
by cell type (Barthel and Goldfeld, 2003; Tsytsykova et al., 2007;
Taylor et al., 2008; Biglione et al., 2011). For example, DH sites
9 kb upstream and 3 kb downstream of the murine gene
act as NFATp-dependent enhancers in T cells and participate
in activation-induced intrachromosomal interactions with the
promoter (Tsytsykova et al., 2007), whereas a myeloid-specific
DH site7 kb upstream of the TSS functions as a matrix attach-
ment region (Biglione et al., 2011).
In this study, we show that a DH site 8 kb upstream of the
human TNF TSS (human hypersensitive site 8 kb [hHS-8]) is
required for and mediates IFN-g-stimulated augmentation
of LPS-induced TNF gene expression in human monocytes/
macrophages. The highly conserved hHS-8 noncoding element
exhibits increased nuclease accessibility in response to IFN-g
stimulation, and interferon regulatory factor 1 (IRF1) is recruited.
Upon subsequent LPS stimulation of IFN-g-primed cells,
increased acetylation of H3K27 and synthesis of enhancer
RNA (eRNA) at hHS-8 occur. IFN-g priming of TNF is abrogated
with the ablation of IRF1, disrupting the IRF1 site in reporter as-
says, or by targeting the IRF1 binding element in hHS-8 with the
catalytically inactive form of Cas9 linked to the Kru¨ppel-associ-
ated box (KRAB) domain of Kox1 (Margolin et al., 1994; Gilbert
et al., 2013) in human monocytic cells. Thus, IRF1 expression
and an intact hHS-8 IRF1 binding element are required for
IFN-g priming of TNF in vivo.
Our results expand the functional role of distal regulatory
elements in the innate immune response to IFN-g priming andhors
highlight the potential of CRISPR/Cas9 technology as a tool for
interrogating the function of distal regulatory elements in human
hematopoietic cells.
RESULTS
IFN-g Promotes Chromatin Accessibility at hHS-8 in the
TNF/LT Locus
As a single stimulus, LPS significantly induced TNFmRNA levels,
whereas IFN-g alone was not sufficient to induce TNF gene
expression in human monocytic THP-1 cells (Figure 1A). How-
ever, priming of cells by pretreatment with IFN-g for 2 hr before
LPS stimulation significantly enhanced TNF mRNA levels
compared with stimulation by LPS alone (Figure 1A). This obser-
vation supported our hypothesis that IFN-g poises the TNF gene
for enhanced transcription in response to LPS by stimulating
chromatin remodeling at the TNF/LT locus.
In order to test this idea, we performed a DNase I hypersen-
sitivity assay (DHA) comparing the landscape and intensity of
hypersensitive sites across the TNF/LT locus in IFN-g-treated
and -untreated THP-1 cells. IFN-g treatment of THP-1 cells
promoted chromatin accessibility at a DH site located8 kb up-
stream of the TNF TSS (hHS-8), as evidenced by IFN-g-depen-
dent enhancement of the DNase I-generated band correspond-
ing to hHS-8 (Figure 1B, compare lane 4 with lane 8). Thus, in a
population of unstimulated human monocytic cells, hHS-8 was
constitutively present, and upon IFN-g treatment, the proportion
of cells in which hHS-8 became accessible to DNase I increased.
We also observed a smaller increase in DNase I cleavage at the
TNF promoter as compared with hHS-8 in response to IFN-g
(Figure 1C, compare lane 4 with lane 8).
To extend our findings to human primary cells, we examined
the effects of IFN-g priming on monocyte-derived macrophages
(MDMs) and confirmed that IFN-g pretreatment significantly
enhanced TNF mRNA levels as compared with stimulation by
LPS alone (Figure 1D). Similar to what we observed in THP-1
cells, IFN-g treatment increased DNase I cleavage at hHS-8 in
primary human MDMs (Figure 1E, compare lane 3 with lane 6).
Furthermore, in both cell types, IFN-g priming prior to LPS stim-
ulation led to enhanced DNase I cleavage as compared with LPS
stimulation alone at hHS-8 (compare lanes 12 and 16 of Fig-
ure 1B, and lanes 9 and 12 of Figure 1E). An examination of
data from the ENCODE database (Thurman et al., 2012) revealed
that a constitutive DH site 8 kb upstream of the TNF TSS was
present in resting primary humanmonocytes in this data set (Fig-
ure S1), confirming our detection of a DH site at this location in
resting monocytic cells. In contrast to THP-1 cells, we observed
no change in DNase I cleavage at the TNF promoter upon IFN-g
stimulation (Figure 1F, compare lane 3 with lane 6). The restric-
tion sites and probe positions for DHAs of both hHS-8 and the
TNF promoter are shown in Figure 1G.
A decrease in total H3 levels is generally reflective of
enhanced chromatin accessibility (Reinke and Ho¨rz, 2004). In or-
der to confirm chromatin remodeling of the TNF/LT locus after
IFN-g stimulation, we next measured total H3 levels at hHS-8
and the TNF promoter by chromatin immunoprecipitation
(ChIP) analysis in THP-1 cells and primary human MDMs under
the same conditions as used for the DHA. Consistent with theCell ReDHA findings, we observed a significant reduction in total
H3 levels at hHS-8 in response to IFN-g in both THP-1 cells
(Figure 1H) and primaryMDMs (Figure 1I), but not at the TNF pro-
moter (Figures 1H and 1I). Furthermore, LPS alone and IFN-g +
LPS stimulation caused a significant reduction of total H3 levels
at both hHS-8 and the TNF promoter in both the THP-1 cells and
MDMs (Figures 1H and 1I). Taken together, these findings show
that sole stimulation with IFN-g remodels the TNF/LT locus at the
distal DNA element hHS-8 to increase nuclease accessibility,
consistent with hHS-8 playing a role in IFN-g-mediated TNF
transcriptional augmentation. In the case of LPS, nuclease
accessibility is increased after stimulation at both the TNF pro-
moter and hHS-8.
IRF1 Binds to hHS-8 in an IFN-g-Inducible Manner
IFN-g is a potent inducer of the transcription factor IRF1
(Pine et al., 1990). An examination of the TNF/LT locus for se-
quences resembling the IRF consensus binding sequence 50-
AANNGAAANGAA-30 (Tamura et al., 2008) revealed putative
IRF sites in both the TNF promoter and hHS-8 (Figure 2A).
To determine whether IRF1 is capable of binding to these se-
quences, we first performed a quantitative DNase I footprinting
analysis with recombinant IRF1 (rIRF1). We found that the pro-
tein binds to the TNF proximal promoter at the 50 boundary of
the predicted site, which lies within a composite binding site of
the TNF enhanceosome that also binds Sp1, Egr1, NFATp, and
Ets in a cell-type-specific manner (Tsai et al., 2000; Figure 2B).
Moreover, rIRF1 also binds to hHS-8 at an IRF binding motif
containing three 50-GAAA-30 motifs (Figure 2C). Using ChIP,
we confirmed that IRF1 binds to hHS-8 in vivo in primary hu-
man MDMs and that its binding is significantly enhanced
upon IFN-g stimulation in vivo. By contrast, IRF1 recruitment
to the promoter was minimal. After LPS treatment of IFN-g-
primed primary human MDMs, IRF1 recruitment to the TNF
promoter increased and IRF1 binding at hHS-8 declined, but
IRF1 binding at hHS-8 remained significantly elevated as
compared with results obtained under nonstimulated condi-
tions (Figure 2D).
In previous comparative analyses of TNF noncoding se-
quences 50 of the TSS in the primate lineage, we delineated
phylogenetic footprints that matched and were predictive of
important TNF regulatory elements (Leung et al., 2000; Baena
et al., 2007). Here, when we specifically focused on the hHS-8
50 bp IRF1 binding element and compared it with correspond-
ing sequences in the primate lineage and with the murine
sequence, we found that the core 50-GAAA-30 motifs were
completely conserved in the primate lineage representatives
down to Callithrix jacchus, the common marmoset (Figure 2E).
Furthermore, even the differences observed between the mouse
and human sequences did not impact IRF1 binding to the site
(Figure S2A). Thus, the exquisite level of sequence conservation
of the IRF1 phylogenetic footprint in hHS-8 strongly suggested
that there is an important function related to the conservation
of these specific sequences. Notably, when we examined the
sequence conservation of the entire 1.3 kb hHS-8 element, we
found it to be70%conserved between human andmouse (Fig-
ure S2B), further supporting the notion that it plays an important
role in TNF gene regulation.ports 9, 1718–1728, December 11, 2014 ª2014 The Authors 1719
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Figure 1. IFN-g Priming Promotes Chromatin Accessibility at hHS-8 in the TNF/LT Locus
(A) IFN-g priming enhances TNF mRNA levels in THP-1 cells stimulated with LPS. Cells were stimulated with IFN-g alone for 3 hr, LPS alone for 1 hr, and both
IFN-g and LPS (IFN-g for 2 hr followed by LPS for 1 hr). TNF mRNA levels were measured after LPS stimulation by qPCR. **p% 0.01; data are represented as
mean ± SEM.
(B and C) IFN-g increases the chromatin accessibility of hHS-8. DHAs using the restriction enzyme ScaI (B) and BamHI (C) allowed for examination of hHS-8 and
the TNF promoter, respectively, in resting and IFN-g-treated THP-1 cells.
(D) IFN-g priming enhances TNFmRNA levels in primary humanMDMs stimulatedwith LPS.MDMswere stimulated as in (A) and RNAwas collected 1 hr after LPS
stimulation. Data from three separate donors; *p% 0.05; data are represented as mean ± SEM.
(E and F) DHAs were performed in resting and IFN-g-treated primary human MDMs as in (B) and (C).
(G) Map of the human TNF/LT locus. DH sites and positions, and directions of transcription of the TNF, LTA, and LTB genes are shown. The positions of the
parental ScaI, parental BamHI, and DNase I digestion products for the DHAs are indicated.
(H and I) IFN-g and LPS decrease nucleosome occupancy at the TNF promoter and hHS-8. ChIP using THP-1 cells (H) and primary humanMDMs (representative
donor, I) measures nucleosome occupancy (total H3 levels) at both the TNF promoter and hHS-8. IFN-g alone decreased total H3 levels at the TNF promoter
(albeit not significantly; p = 0.054) in THP-1 cells; this was not repeated in the MDM donor. Data from three separate experiments; *p% 0.05, ***p% 0.001; data
are represented as mean ± SEM.
See also Figure S1.IRF1 Is Required for Enhanced TNF Expression in
IFN-g-Primed Monocytes and Macrophages
IRF1 is a member of the nine-member IRF family of transcrip-
tion factors, all of which share a cognate binding motif (Tamura1720 Cell Reports 9, 1718–1728, December 11, 2014 ª2014 The Autet al., 2008). Although transcription of IRF1, IRF8, and IRF9
is induced by IFN-g treatment, IRF1 is thought to be the domi-
nant IFN-g-inducible IRF family member (Tamura et al., 2008).
To test for a specific and nonredundant functional role of IRF1hors
in IFN-g-induced enhancement of TNF expression, we examined
bone-marrow-derived macrophages (BMDMs) from wild-type
and IRF1-deficient (Irf1/) mice (Figures 2F and 2G). BMDMs
from wild-type control mice responded to IFN-g priming and
secreted significantly higher levels of TNF protein after LPS stim-
ulation as compared with cells stimulated with LPS alone (Fig-
ures 2F and 2G). By contrast, whereas LPS-induced TNF protein
production in Irf1/BMDMswas similar to protein levels in wild-
type BMDMs, priming by IFN-g pretreatment was eliminated in
the IRF1-deficient cells.
To extend this finding to human monocytic cells, we next con-
structed lentiviral expression vectors encoding a short hairpin
RNA (shRNA) targeting IRF1 transcripts or a nonspecific control
shRNA, and demonstrated that IFN-g-induced IRF1 mRNA
levels were significantly inhibited in the cells carrying the shRNA
targeting IRF1 (Figure 2H). We then tested the ability of IFN-g
priming to prime LPS-induced TNF mRNA expression in the
IRF1-deficient cells and found that IFN-g priming was abro-
gated, whereas LPS induction of TNF transcription was not
affected (Figure 2I). These experiments thus demonstrated that
(1) IRF1 is significantly recruited to the highly conserved hHS-8
element upon sole IFN-g stimulation in vivo, but is only minimally
recruited to the human TNF promoter, and (2) IRF1 is necessary
for IFN-g priming of LPS-stimulated TNF gene expression in both
murine macrophages and human monocytic cells, and thus
other IRF family members cannot compensate for its loss in
IFN-g priming of TNF.
hHS-8 Functions as an IFN-g-Inducible, IRF1-Dependent
Enhancer of TNF Gene Expression
To determine whether hHS-8 can function as an IFN-g-inducible
enhancer element, we inserted the 1.3 kb hHS-8 element up-
stream of the TNF promoter in a luciferase reporter construct
and compared its transcriptional activity with the activity of a re-
porter construct containing only the human TNF promoter (with
sequences up to 982 bp upstream of the TNF TSS). As shown
previously (Tsai et al., 2000), the human TNF promoter alone is
LPS inducible (Figure 3A). Consistent with our findings for the
endogenous TNF gene (see Figure 1), sole treatment with IFN-
g did not activate expression of the TNF promoter-reporter
construct (Figure 3A). Furthermore, IFN-g priming did not
enhance LPS-induced transcriptional activity (Figure 3A, p =
0.653). Thus, the TNF promoter alone was not sufficient to
mediate IFN-g priming of transcription. By contrast, when the
1.3 kb hHS-8 sequence was inserted upstream of the TNF pro-
moter, we found a significant enhancement of IFN-g-primed,
LPS-stimulated reporter expression (Figure 3A, p = 0.001). Strik-
ingly, the introduction of mutations that disrupt IRF1 binding
within the context of the otherwise isogenic 1.3 kb hHS-8
element (Figure 3B) completely abolished IFN-g priming of
LPS-driven TNF promoter activity (p = 0.001), but did not impair
LPS induction of the gene (Figure 3A, p = 0.222). We also note
that consistent with the regulation of the endogenous gene in
monocytic cells (Figures 1A and 1D), sole treatment with IFN-g
did not activate expression of the wild-type TNF promoter +
hHS-8-reporter construct (Figure 3A). These data thus demon-
strate that the TNF promoter alone is unable to drive enhanced
transcription in response to IFN-g priming, but gains this capac-Cell Reity when linked to the IRF1-dependent inducible hHS-8 regula-
tory element. This is in contrast to the IL12A promoter, which
contains an IRF1 binding site and is sufficient for IFN-g priming
of LPS-driven transcriptional activation (Liu et al., 2003).
IFN-g Priming Enhances H3K27 Acetylation at hHS-8
upon LPS Stimulation
In addition to increased chromatin accessibility, activated
enhancers are associated with enrichment in H3K27ac levels
(Calo and Wysocka, 2013). Therefore, we next investigated
whether H3K27ac levels were altered at hHS-8 or the TNF pro-
moter during IFN-g priming. At the TNF promoter, although we
saw no change in H3K27ac levels in response to IFN-g alone,
H3K27ac enrichment increased dramatically after the single
LPS stimulus (Figure 3C), and there was no further enhancement
in H3K27ac levels in response to IFN-g priming followed by LPS
stimulation (Figure 3C). By contrast, although solitary LPS or
IFN-g treatment of THP-1 cells did not cause an increase in
H3K27ac levels at hHS-8, H3K27ac enrichment increased signif-
icantly at hHS-8 in cells that had first been primed with IFN-g and
then stimulated with LPS (Figure 3C). We note that the acetyl-
transferases CBP/p300 are inducibly recruited to the TNF pro-
moter after LPS stimulation (Tsai et al., 2000), and that IFN-g
stimulation alone is not sufficient to induce p300 recruitment to
hHS-8, which requires LPS stimulation (Figure S3), consistent
with the pattern of enhanced H3K27ac levels after dual IFN-g
and LPS treatment.
eRNA Is Synthesized at hHS-8 during IFN-g Priming
Since eRNA production is associated with functional enhancer
elements (Jiao and Slack, 2014), we next investigated whether
hHS-8 eRNA was transcribed during IFN-g priming and LPS
stimulation of THP-1 cells and primary human MDMs. In both
cell types, similar to our findingswith TNF gene transcription initi-
ated at the promoter, IFN-g as a single stimulus did not induce
transcription of hHS-8 eRNA (Figures 3D and 3E). However,
IFN-g priming of THP-1 cells prior to LPS stimulation significantly
enhanced hHS-8 eRNA synthesis as compared with stimulation
by LPS alone (Figure 3D), and a similar effect was seen in MDMs
from a representative donor (Figure 3E).
hHS-8 Is Required for IFN-g Augmentation of TNF Gene
Expression In Vivo
Finally, to demonstrate the functional role of hHS-8 in IFN-g prim-
ing within the endogenous chromatin environment of the TNF/LT
locus, we employed CRISPR/Cas9 technology. We used the
catalytically ‘‘dead’’ version of codon-optimized Cas9 (dead
Cas9 or dCas9) linked to the KRAB repressive domain (Gilbert
et al., 2013) to specifically target the IRF1 binding element within
hHS-8. We modified the lentiCRISPR lentiviral vector developed
byShalemet al. (2014) to encode the far-red reporterE2-Crimson,
andmade nucleotide changes to theCas9 sequence to introduce
the D10A and H840A mutations to generate dCas9. To enhance
the targeting strategy, we incorporated two human pol III pro-
moters into this lentivirus to drive expression of two unique guide
RNAs in order to cover the entire 50 bp IRF1 binding element
(CRISPR-hHS-8). As a positive control, we designed a lentivirus
encoding two guide RNAs directed against the TATAA box andports 9, 1718–1728, December 11, 2014 ª2014 The Authors 1721
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Figure 2. IRF1 Binds to hHS-8 in an IFN-g-Inducible Manner
(A) TNF/LT locus with partial sequences and binding-site positions of transcription factors for both the TNF promoter and hHS-8.
(B) rIRF1 binds to the TNF promoter. Quantitative DNase I footprinting analysis of the TNF promoter (200 to +1) and increasing concentrations of rIRF1. Sense
and antisense strand with G+A ladder and BSA control. Bars mark areas of rIRF1 binding at 172 to 136.
(C) rIRF1 binds to hHS-8. Quantitative DNase I footprinting analysis of hHS-8 (7031 to 6782) was performed as in (B). Bars mark areas of rIRF1 binding at
6833 to 6782.
(D) IRF1 is recruited to hHS-8 in an IFN-g-inducible manner. ChIP using primary human MDMs and analyzing IRF1 recruitment to the TNF promoter and hHS-8.
Data from three separate donors; *p% 0.05, **p% 0.01; data are represented as mean ± SEM.
(E) IRF1 binding sites in hHS-8 are highly conserved in all of the primate species examined. Critical 50-GAAA-30 motifs for IRF1 binding are highlighted.
(legend continued on next page)
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Figure 3. hHS-8 Functions as an IFN-g-
Inducible, IRF1-Dependent Enhancer of TNF
Gene Expression
(A) Disruption of IRF1 binding to hHS-8 abolishes
inducible enhancer function and thus enhanced
TNF gene expression induced by IFN-g priming.
Constructs using the pGL3-Basic luciferase vector
were transfected into J774 cells and stimulated
with IFN-g alone for 8 hr, LPS alone for 6 hr, and
both IFN-g and LPS (IFN-g for 2 hr followed by LPS
for 6 hr). TNF, the TNF promoter; hHS-8, the entire
sequence of hHS-8 (1,250 bp); muthHS-8, hHS-8
with mutations that disrupt IRF1 binding. Data from
three separate experiments; ***p% 0.001; data are
represented as mean ± SEM.
(B) Nucleotide changes in the critical 50-GAAA-30
motifs disrupt rIRF1 binding. An electrophoretic
mobility shift assay was performed with rIRF1 and
wild-type and mutant radiolabeled P32 oligonucle-
otides (sequences for positions 6838 to 6785).
(C) Activation of hHS-8 enhancer function corre-
sponds with increased H3K27ac prevalence at
hHS-8. ChIP analyzing H3K27ac prevalence was
performedwith THP-1 cells and analyzing H3K27ac
prevalence at the TNF promoter and hHS-8. Data
from three separate experiments; *p % 0.05; data
are represented as mean ± SEM.
(D and E) IFN-g + LPS induces hHS-8 eRNA tran-
scription. hHS-8 eRNA (RNA sequence containing
IRF1 binding sites) were measured after LPS stim-
ulation in THP-1 cells (D) and primary humanMDMs
(representative donor, E). Data from three separate
experiments; *p % 0.05; data are represented as
mean ± SEM.
See also Figure S3.a core Sp1 site within the TNF core promoter (CRISPR-TNFp). As
a negative control, we generated a lentivirus encoding two guide
RNAs that contain at least two mismatches with any human
genomic sequence and for which the closest genomic targets
lack the required NGG protospacer adjacent motif (PAM) at their
30 ends (CRISPR-Ctrl; sequences and strategy are shown in Fig-
ure S4 and Table S1). After transducing THP-1 cells with each
lentivirus, we enriched for E2-Crimson+ cells by two rounds of
sorting, which resulted in >95% E2-Crimson+ cells at the time
of experimental analysis (Figure 4A).
Consistent with the requirement of the TATAA box and the
core TNF promoter Sp1 site for LPS-driven TNF transcription(F and G) Enhanced TNF expression induced by IFN-g priming is abrogated in
stimulated, and TNF protein levels in supernatants were measured by ELISA after
0.05, ***p% 0.001; data are represented as mean ± SEM.
(H) IRF1 mRNA levels induced by IFN-g are silenced by IRF1 shRNA. THP-1 cells
shRNA encoding a scrambled sequence were stimulated with IFN-g alone for 3
mean ± SEM.
(I) Enhanced TNF gene expression induced by IFN-g priming is abrogated in hum
and control shRNAwere stimulated, and TNFmRNA levels weremeasured (shown
are represented as mean ± SEM.
See also Figure S2.
Cell Re(Goldfeld et al., 1990; Falvo et al., 2000a), LPS-stimulated TNF
gene expression was ablated (>98%) in the CRISPR-TNFp cells
as comparedwith the CRISPR-Ctrl cells (Figure 4B, left). Further-
more, we showed that TNF transcriptional repression was spe-
cific to the TNF gene, since induction of IL-6 mRNA synthesis
by LPS was highly inducible in both the CRISPR-Ctrl and
CRISPR-TNFp cells (Figure 4B, right).
We then examined the impact of targeting the hHS-8
IRF1 binding element with dCas9-KRAB upon IFN-g priming of
LPS-stimulated TNF gene transcription. As shown in the left
panel of Figure 4C, there was no difference between the
CRISPR-Ctrl and CRISPR-hHS-8 cells in their transcriptionalIRF1-deficient murine BMDMs. Wild-type (F) and Irf1/ (G) BMDMs were
LPS stimulation. Data from three separate experiments, each with n = 3; *p%
that constitutively express lentivirally delivered shRNA targeting IRF1 or control
hr. Data from three separate experiments; *p% 0.05; data are represented as
an monocytes where IRF1 expression is silenced. THP-1 cells expressing IRF1
relative to LPS values). Data from three separate experiments; *p% 0.05; data
ports 9, 1718–1728, December 11, 2014 ª2014 The Authors 1723
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Figure 4. hHS-8 IRF1 Binding Sites Are Required for IFN-g Priming of TNF Gene Expression In Vivo
(A) Flow-cytometry data demonstrating that >95% of THP-1 cells were successfully transduced with the CRISPR-Ctrl, CRISPR-TNFp, and CRISPR-hHS-8
lentiviruses at the time of experimental analysis.
(B) Targeting of the TNF promoter with dCas9-KRAB. CRISPR-Ctrl, and CRISPR-TNFp THP-1 cells wasmock stimulated or stimulated with LPS for 1 hr, and TNF
and IL-6mRNAwere quantitated after normalization to the housekeeper cyclophilin B. Data from at least three independent experiments are shown; ***p% 0.001;
data are represented as mean ± SD.
(C) Targeting hHS-8 with dCas9-KRAB blocks priming of TNF. CRISPR-Ctrl and CRISPR-hHS-8 THP-1 cells were mock stimulated, stimulated with LPS for 1 hr,
or stimulated with IFN-g for 2 hr and LPS for 1 hr. For analysis of TNF expression, data are presented as fold inductions over unstimulated TNF mRNA levels to
control for baseline constitutive TNF transcription in THP-1 cells. For analysis of IL6 expression, data are presented as fold induction of primed versus nonprimed
conditions due to the absence of detectable IL-6 transcripts in the absence of stimulation. Data from three independent experiments are presented; **p < 0.01;
data are represented as mean ± SD.
See also Figure S4.response to LPS, and the gene was highly inducible in both, indi-
cating that the dCas9-KRAB fusion did not have a general
repressive effect upon TNF activation in a stimulus-independent
manner. However, when the CRISPR-hHS-8 cells were primed
with IFN-g prior to LPS stimulation, augmentation of TNF gene
expression was abolished, but it proceeded normally in the
CRISPR-Ctrl cells (Figure 4C, left). As a control for specificity,
we also examined IFN-g priming of the endogenous IL6 gene
in the CRISPR-hHS-8 cells and found that IFN-g priming of IL6
gene transcription was not affected in the CRISPR-hHS-8 cells
(Figure 4, right), indicating that loss of IFN-g priming at the
TNF/LT locus was specific and not due to off-target effects of
the hHS-8 guide RNAs. These findings provide a fundamental
functional demonstration that hHS-8 is required for IFN-g prim-
ing of LPS-induced TNF gene expression in vivo.
DISCUSSION
We have demonstrated that IFN-g priming of TNF requires an
exquisitely conserved distal regulatory element, hHS-8, which
lies 8 kb upstream of the TNF TSS. Upon exposure to IFN-g,
hHS-8 becomes more accessible to DNase I and IRF1 is re-
cruited. Once the LPS signal occurs, levels of H3K27ac are en-
riched and eRNA is transcribed, which corresponds to
augmented TNF gene expression. Both ablation of IRF1 in mu-
rine macrophages or human monocytic cells and targeting of
the endogenous IRF1 binding element in hHS-8 with a dCas9-
KRAB fusion protein in human monocytic cells abolish IFN-g
priming of LPS-stimulated TNF transcription. Thus, a combina-
tion of IFN-g-induced chromatin accessibility and IRF1 binding1724 Cell Reports 9, 1718–1728, December 11, 2014 ª2014 The Autat the distal hHS-8 enhancer poise the TNF/LT locus for aug-
mented TNF gene expression in response to the TLR signal.
These experiments thus provide a fundamental functional de-
monstration that a distal regulatory element enhances expres-
sion of a specific gene during classical macrophage activation.
A major question regarding the epigenetic and transcriptional
mechanisms underlying IFN-g priming at the TNF/LT locus is:
Are these mechanisms unique to TNF or are they (or similar
mechanisms) involved in the priming of other inflammatory
genes? In contrast to our finding that a distal enhancer element
is necessary for priming of TNF, it was previously shown that the
IL12A promoter is sufficient for IFN-g priming of LPS-induced
IL12A gene expression (Liu et al., 2003), and the IL6 promoter
is sufficient for IFN-g priming of IL6 in response to stimulation
by TNF (Sance´au et al., 1995).
In a recent study, Qiao et al. (2013) showed that IFN-g + M-
CSF treatment of primary human monocytes for 24 hr led to
increased histone acetylation and STAT1 recruitment at the pro-
moters and distal sites upstream of the IL6, IL12B, and TNF
genes as compared with M-CSF treatment alone. They also
found that subsequent LPS activation after IFN-g + M-CSF pre-
treatment led to enhanced H3K27ac enrichment at the pro-
moters and distal sites upstream of the IL6, IL12B, and TNF
genes. They reported synthesis of eRNA at the IL6 and IL12 up-
stream sequences; however, they did not examine the regions
upstream of the TNF gene for eRNA production, IRF1 binding,
or enhancer function. The authors mined the ENCODE database
(http://genome.ucsc.edu/ENCODE/) and found that DNase I
hypersensitive sites identified in CD14+ human monocytes cor-
responded to the general upstream regions where increasedhors
histone acetylation and STAT1 recruitment were detected by
ChIP sequencing. This led them to conclude that these distal
noncoding elements are involved in IFN-g augmentation of
LPS-induced gene expression, although no functional analyses
linking epigenetic modifications and changes in transcription
factor recruitment to gene regulation were shown (Qiao et al.,
2013). Indeed, only marginal (and nonsignificant) enhancement
of SV40 promoter-driven expression by upstream sequences
from the IL6 and IL12B loci in reporter assays in response to
IFN-g + LPS activation was observed.
By contrast, we saw enhanced H3K27 acetylation at hHS-8
only after IFN-g + LPS stimulation, and not after IFN-g treatment
alone. Furthermore, we observed that hHS-8 dramatically and
significantly enhanced TNF promoter-driven reporter expression
in response to IFN-g + LPS versus LPS alone, and conferred a
priming capacity to the otherwise ‘‘nonprimable’’ TNF promoter
(Figure 3A). Moreover, disruption of the IRF1 binding element in
hHS-8 abolished the ability of this 1.3 kb enhancer to augment
TNF promoter-driven reporter expression. Finally, precise tar-
geting of dCas9-KRAB to the hHS-8 IRF1 binding element within
the endogenous chromatin environment inhibited IFN-g priming
of LPS-induced TNF gene expression, clearly demonstrating the
importance of this upstream region for priming of this critical in-
flammatory gene.
Thus, although the TNF hHS-8 functions as an essential prim-
ing enhancer element, to date, the sites upstream of IL6 and
IL12B have not been demonstrated to have a functional role in
the regulation of these genes. It will be of interest to determine
in future studies whether the regions upstream of the IL6 and
IL12B genes identified by Qiao et al. (2013) play a role in IFN-g
priming of LPS-induced gene expression at these loci, or
whether the epigenetic and other changes seen at these sites
in response to IFN-g stimulation are bystander marks of a local-
ized, ‘‘primed’’ chromatin environment.
Our data suggest the possibility that IRF1 may function at
hHS-8 as a ‘‘pioneer factor’’ (Zaret and Carroll, 2011) for
enhanced TNF gene expression in primed monocytes and
macrophages. In this scenario, IRF1 binding to hHS-8 would
promote increased DNase I accessibility at hHS-8 and the
recruitment of chromatin-remodeling complexes and addi-
tional factors that poise this element for rapid activation in
response to the LPS signal. Indeed, several studies have iden-
tified a class of enhancers, termed ‘‘poised enhancers,’’ that
are linked to inactive genes and are distinguished by the
absence of H3K27ac (Zentner et al., 2011; Creyghton et al.,
2010; Rada-Iglesias et al., 2011; Cotney et al., 2012). When
activated, these poised enhancers become enriched in
H3K27ac (Rada-Iglesias et al., 2011). This is reminiscent of
the LPS-dependent acetylation of hHS-8 that we observed
upon LPS stimulation of IFN-g-primed cells. We note that
IRF1 was previously shown to recruit CBP/p300 (Marsili
et al., 2004) and PCAF (Masumi et al., 1999). We imagine
that upon IFN-g stimulation of monocytes/macrophages, there
is an increase in the percentage of cells in the sample popula-
tion in which hHS-8 is ‘‘open’’ and associated with IRF1,
resembling a poised enhancer ready for activation. Indeed,
IRF1 could function as a beacon for enhanced recruitment of
CBP/p300 to hHS-8 following IFN-g + LPS stimulation, leadingCell Reto H3K27 acetylation and the commissioning of hHS-8 as an
active enhancer to augment transcription of TNF.
Finally, by demonstrating that specific targeting of dCas9-
KRAB to the IRF1 binding element in hHS-8 within its endoge-
nous chromatin environment abrogates IFN-g augmentation of
LPS-induced TNF transcription in human monocytic cells, we
have confirmed that hHS-8 is required for priming of this critical
early response gene during classical macrophage activation.
Our data also suggest that applying dCas9-KRAB technology
to the functional interrogation of global data sets such as
ENCODE would be of particular value. Furthermore, by probing
the function of distal elements linked to specific genes, we can
achieve a fundamental understanding of the role of long-range
interactions in controlling cell-type- and/or stimulus-specific
gene expression.
EXPERIMENTAL PROCEDURES
Cell Culture and Stimulations
THP-1 cells were maintained in RPMI-1640 supplemented with 10% fetal
bovine serum (FBS). J774 cells were maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM) supplemented with 10% FBS. For primary human
MDMs, enriched populations of human monocytes were isolated from healthy
human donor buffy coats using a CD14+ positive selection kit (STEMCELL
Technologies). MDMs were obtained after 6 days of culture in RPMI-1640 me-
dium supplemented with 5% human serum AB (GemCell) and GM-CSF (50 ng/
ml; Peprotech). Cells were treated with IFN-g (100 ng/ml; R&D Systems) and
LPS (100 ng/ml; Sigma-Aldrich, E. coli O111:B4).
RNA Extraction and Real-Time Quantitative RT-PCR
Total RNA was extracted from cells with the use of the QuickRNA Mini kit
(Zymo) and treated with the Turbo DNA-free kit (Invitrogen). cDNA was synthe-
sized from total RNA with M-MLV reverse transcriptase (Invitrogen) and
20-residue oligo (dT; Invitrogen). eRNA was synthesized from total RNA
with hHS-8 eRNA reverse primer. TNF mRNA levels were measured by the
change-in-threshold (DDCt) method based on real-time quantitative PCR
(qPCR) in an iCycler iQ (Bio-Rad) with SyberGreen Master Mix (Invitrogen)
and primers recognizing exon 4 and exon 3 of the human TNF gene, the human
GAPDH gene, and the human IRF1 gene. Primers used for ChIP and cDNA
measurements by real-time qPCR are shown in Table S1.
DHAs
DHAs were performed using both THP-1 cells and primary human MDMs.
MDMs were detached from the culture surface using TrypLE (Life Technolo-
gies). Cells were harvested, washed with PBS, and resuspended in RSB buffer
(10mMTris-HCl [pH 7.4], 10mMNaCl, and 3mMMgCl2). Cells were lysedwith
lysis buffer (0.5% NP-40 in 13 RSB buffer) on ice for 5 min. Resuspended
nuclei in RSB buffer were treated with DNase I (40 ng/ml) at 37C for 5 min.
DNase I activity was quenched upon addition of a stop solution (0.6 M NaCl,
20 mM Tris-HCl [pH 8.0], 10 mM EDTA, and 1% SDS). Samples were treated
with Proteinase K at 56C overnight (O/N). DNA was digested with ScaI and
BamHI restriction enzymes and analyzed by Southern blotting using a radiola-
beled P32 probe corresponding to the coding region of LTA, with 10 mg of DNA
used for each lane.
ChIP
ChIP assays were performed with anti-IRF1 (H-205; Santa Cruz Biotech-
nology), Rb IgG (Diagenode), anti-H3K27me3 (C36B11; Cell Signaling Tech-
nology), anti-H3K27ac (Active Motif), and anti-H3 (Abcam). THP-1 cells and
primary human MDMs were treated (IFN-g 100 ng/ml, LPS 100 ng/ml), fixed
with 10% formaldehyde for 15 min, treated with 2.5 M glycine for 5 min, har-
vested, washed with PBS, lysed with 0.25% Triton X-100 and 0.5% NP-40
for 5 min, centrifuged at 1,200 rpm for 10 min, resuspended in 1% SDS lysis
buffer, and sonicated for 5 min for four cycles in a Biorupter. Sonicated DNAports 9, 1718–1728, December 11, 2014 ª2014 The Authors 1725
was set up for immunoprecipitation O/N and DNA-protein complexes were
recovered by adding Protein A/G Plus Agarose Beads (Thermo Scientific) for
3 hr. Samples were washed six times with 1 ml of wash buffer and treated
with proteinase K at 65C O/N. Samples were treated with phenol/chloroform
before O/N ethanol precipitation. DNA fragments for IRF1 recruitment were
analyzed by real-time qPCR with SYBER Green Master Mix (Invitrogen) and
primer sets for regions 244 to 82 (promoter) relative to the TNF TSS, and
6842 to 6737 (hHS-8) relative to the TNF TSS (Table S1). Rb IgG percent
input values were subtracted from IRF1 percent input values. DNA fragments
for H3K27me3 and H3K27ac analysis were analyzed by real-time qPCR using
Jumpstart Taq ReadyMix for Quantitative PCR (Sigma-Aldrich) and primer/
probe sets for the TNF promoter and hHS-8 (Table S1). H3K27me3 and
H3K27ac percent input values were normalized to H3 percent input values.
DNase I Footprinting Assay
Radiolabeled P32 fragments of the TNF promoter (200 to +1) and hHS-8
(7031 to 6782) regions were incubated with recombinant IRF1 protein (Ab-
cam) and treated with diluted DNase I at room temperature for 5 s before
enzyme activity was quenched with a stop solution (0.13 mM EDTA, 0.5%
SDS, and tRNA). Samples were treated with phenol chloroform and DNA was
precipitatedO/N at20C. G+A ladder was treatedwith 4% formic acid, radio-
labeled with P32, treated with 1 M piperidine, and precipitated with n-butanol.
DNA fragments were separated by electrophoresis on an 8% sequencing gel.
Mice
C57BL/6J mice and B6.129S2-Irf1tm1Mak/J mice (6–8 weeks old) were pur-
chased from The Jackson Laboratory. Experimental procedures were done
in accordance with the Institutional Animal Care and Use Committee and the
Harvard Medical Area Standing Committee on Animals.
Isolation, Culture, and Stimulation of Murine BMDMs
For the generation of murine BMDMs, bonemarrow cells of wild-type or Irf1/
mice (6–8 weeks old) were cultured in DMEM supplemented with 10% FBS,
10% L929 cell conditioned medium (LCCM), 100 U/ml penicillin, 100 mg/ml
streptomycin, and 2 mM L-glutamine. Cells were fed on day 5 and media
were changed on day 7, 3 hr before mIFN-g (100 ng/ml; R&D Systems) and
LPS (100 ng/ml; Sigma-Aldrich, E. coli O111:B4) treatment. Supernatant was
collected 2, 4, and 6 hr after treatment.
shRNA
The lentiviral plasmid pLKO.1 expressing shRNA targeting human IRF1 was
purchased from the RNAi Consortium (TRC) Lentiviral shRNA Library (Thermo
Scientific). Clone TRCN0000014668 with a target sequence of 50-CGTG
TGGATCTTGCCACATTT-30 was validated in our laboratory. Control shRNA
encodes a scrambled sequence. Lentiviruses encoding shRNA sequences
were generated by transfecting the packaging cell line HEK293T with the
shRNA-encoding pLKO.1 plasmids in combination with the packaging plasmid
psPAX2 and the envelope plasmid pMD2.G using Effectene transfection re-
agent (QIAGEN). Supernatants were collected 48 hr posttransfection, clarified
by centrifugation, and stored at 80C. THP-1 cells were transduced with the
lentiviral particles by culturing the cells with supernatants from the virus-pro-
ducing cells in the presence of 8 mg/ml polybrene (Millipore) and spinoculation
for 2 hr at 2,000 rpm. Successfully transduced cells were selected and
expanded by treatment with 0.8 mg/ml puromycin.
Electrophoretic Mobility Shift Assay
Radiolabeled 32P oligonucleotides were added to THP-1 nuclear extracts or
recombinant IRF1 protein (Abcam) in a binding buffer solution (10 mM Tris-
HCl [pH 7.5], 53 mM NaCl, 1 mM dithiothreitol, 0.01% Nonidet-P40, 5% glyc-
erol, and 0.05 mg/ml of double-stranded poly(dI-dC)) at room temperature for
30 min. In supershift experiments, samples were incubated with 2 mg of anti-
IRF1 (H-205; Santa Cruz Biotechnology). Protein-DNA complexes were sepa-
rated by electrophoresis on a 5% PAAG gel.
Sequencing
Cell lines and samples of blood or DNA from representative individuals of the
primate species and subspecies were procured as previously described1726 Cell Reports 9, 1718–1728, December 11, 2014 ª2014 The Aut(Leung et al., 2000; Baena et al., 2007). Genomic DNA was isolated using
the QIAamp DNA Blood Kit (QIAGEN). Sequence alignments were performed
using ClustalW2 multiple sequence alignment provided by EMBL-EBI.
Plasmids
Construction of the TNF promoter-driven luciferase reporter was previously
described (Tsai et al., 2000). The TNF promoter with hHS-8 plasmid was con-
structed by inserting nucleotides7,833 to6,583 relative to the TNF TSS into
the TNF promoter-driven luciferase reporter construct using MluI and NheI re-
striction enzyme sites. The TNF promoter with mutated hHS-8 plasmid was
constructed by circular site-directed mutagenesis.
Luciferase Reporter Assay
J774 cells were transfected with luciferase reporter constructs using an Effec-
tene Transfection Reagent Kit (QIAGEN). Cells were treated with mIFN-g
(100 ng/ml; R&D Systems) and LPS (100 ng/ml, Sigma-Aldrich, E. coli
O111:B4). Luciferase assays were performed 8 hr after treatment under the
Dual Luciferase Reporter Assay System (Promega) using a Dynex luminometer
and Renilla luciferase (pRL-TK) as a control.
CRISPR/dCas9 Analysis
The plasmids pCas9_GFP (Addgene plasmid 44719, deposited by Kiran Mu-
sunuru) and LentiCRISPR (Addgene plasmid 49535, deposited by Feng Zhang)
were obtained from Addgene. D10A and H840A substitutions were introduced
into the Cas9 coding region of pCas9_GFP by overlapping PCR in order to
generate the catalytically inactive dCas9 as described previously (Qi et al.,
2013). The KRAB coding sequence was ordered as a gBlock fragment from In-
tegrated DNA Technologies and cloned in-frame at the 30 end of the dCas9
coding sequence. After the E2-Crimson coding sequence (Clontech), pre-
ceded by the P2A self-cleaving peptide DNA sequence, was substituted for
the 2A-puromycin resistance gene in LentiCRISPR, the dCas9-KRAB
sequence was amplified and substituted for Cas9 in LentiCRISPR upstream
and in-frame with the 2A-E2-Crimson sequence. To generate guide RNA, we
first cloned a cassette containing the tracr RNA sequence from LentiCRISPR
followed by a TTTTTTT termination signal and the 98 bp H1 promoter
sequence into plasmid pSP73 (Promega). This plasmidwas used as a template
with the primers shown in Table S1 to create individual PCR products consist-
ing of a BsmBI site-20bp target#1-tracr-term-H1pro-20bp target#2-BsmBI
site. This was then cloned into the BsmBI sites of the modified lentiCRISPR
vector, with the cassette placed after the U6 promoter and before the tracr-
term sequence already present in the vector. The sequences in the TNF pro-
moter and hHS-8 that were targeted with this dual guide RNA vector system
are shown in Figure S4. For the control lentivirus, we used the 20 bp targets
50gttcgtgtcgtcgtgtctta-30 and 50gaatctagcggtctgacatt-30 because these se-
quences have at least two mismatches with any 20 bp sequence in the human
genome, and the closest matches in the human genome do not possess the 50-
NGG-30 PAM sequence required for full Cas9 binding.
The CRISPR/dCas9-KRAB lentiviruses were prepared and THP-1 cells were
transduced as described above for the shRNA lentiviruses, except that virus-
containingmediumwas centrifuged over 20%sucrose at 11,500 rpm for 4 hr to
increase the lentiviral concentration prior to spinoculation. After expansion of
transduced cells, E2-Crimson+ cells were enriched by fluorescence-activated
cell sorting at two time points over the course of 3 weeks. For experimental
analysis, cells were seeded at 5 3 105 cells/ml and stimulated with IFN-g
and LPS, and RNA isolation, cDNA synthesis, and qPCR were performed as
described above using primer sets for cyclophilin B, TNF, and IL-6 as shown
in Table S1.
SUPPLEMENTAL INFORMATION
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